Hot Features
プレミアム
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-02 | Mr. Dalton E. SmartSenior VP of Finance, Principal Accounting Officer & Global Controller | 251.00 | 28.15k | Derivative Exercise and Retained Stock | 112.16 | 9.39k | 2.75% |
| 2026-05-02 | Mr. Dalton E. SmartSenior VP of Finance, Principal Accounting Officer & Global Controller | -132.00 | 0.00 | Derivative Exercise and Sale | 112.16 | 9.39k | - |
| 2026-05-02 | Mr. David R. MaraldoExec. VP & President of Merck Manufacturing Division | 393.00 | 44.08k | Derivative Exercise and Retained Stock | 112.16 | 26.57k | 1.50% |
| 2026-05-02 | Mr. David R. MaraldoExec. VP & President of Merck Manufacturing Division | -159.00 | 0.00 | Derivative Exercise and Sale | 112.16 | 26.57k | - |
| 2026-04-29 | Mr. Chirfi GuindoExec. VP of Strategic Access, Policy & Communications | 998.00 | 109.81k | Derivative Exercise and Retained Stock | 110.03 | 61.67k | 1.64% |
| 2026-04-29 | Mr. Chirfi GuindoExec. VP of Strategic Access, Policy & Communications | -969.00 | 0.00 | Derivative Exercise and Sale | 110.03 | 61.67k | - |
| 2026-04-29 | Mr. Sanat Chattopadhyayインサイダー | 1.47k | 161.41k | Derivative Exercise and Retained Stock | 110.03 | 200.68k | 0.74% |
| 2026-04-29 | Mr. Sanat Chattopadhyayインサイダー | -1.13k | 0.00 | Derivative Exercise and Sale | 110.03 | 200.68k | - |
| 2026-04-29 | Mr. Richard R. DeLucaExec. VP & President of Merck Animal Health | 1.28k | 140.51k | Derivative Exercise and Retained Stock | 110.03 | 162.86k | 0.79% |
| 2026-04-29 | Mr. Richard R. DeLucaExec. VP & President of Merck Animal Health | -1.24k | 0.00 | Derivative Exercise and Sale | 110.03 | 162.86k | - |
| 2026-04-29 | Mr. David Michael WilliamsExec. VP and Chief Information & Digital Officer | 698.00 | 76.80k | Derivative Exercise and Retained Stock | 110.03 | 31.72k | 2.25% |
| 2026-04-29 | Mr. David Michael WilliamsExec. VP and Chief Information & Digital Officer | -679.00 | 0.00 | Derivative Exercise and Sale | 110.03 | 31.72k | - |
| 2026-04-29 | Mr. Dalton E. SmartSenior VP of Finance, Principal Accounting Officer & Global Controller | -483.00 | 0.00 | Derivative Exercise and Sale | 110.03 - 110.95 | 9.14k | - |
| 2026-04-29 | Mr. Dalton E. SmartSenior VP of Finance, Principal Accounting Officer & Global Controller | 925.00 | 102.06k | Derivative Exercise and Retained Stock | 110.03 - 110.95 | 9.14k | 11.26% |
| 2026-04-29 | Dr. Dean Y. LiExec. VP & President of Merck Research Laboratories | 2.40k | 263.63k | Derivative Exercise and Retained Stock | 110.03 | 94.43k | 2.60% |
| 2026-04-29 | Dr. Dean Y. LiExec. VP & President of Merck Research Laboratories | -2.33k | 0.00 | Derivative Exercise and Sale | 110.03 | 94.43k | - |
| 2026-04-29 | Ms. Jennifer L. ZacharyExec. VP & General Counsel | 1.50k | 164.71k | Derivative Exercise and Retained Stock | 110.03 | 70.90k | 2.16% |
| 2026-04-29 | Ms. Jennifer L. ZacharyExec. VP & General Counsel | -1.45k | 0.00 | Derivative Exercise and Sale | 110.03 | 70.90k | - |
| 2026-04-29 | Ms. Betty D. LarsonExec. VP & Chief HR Officer | 7.58k | 839.41k | Derivative Exercise and Retained Stock | 110.03 - 110.95 | 13.77k | 122.27% |
| 2026-04-29 | Ms. Betty D. LarsonExec. VP & Chief HR Officer | -5.86k | 0.00 | Derivative Exercise and Sale | 110.03 - 110.95 | 13.77k | - |
| 2026-04-29 | Ms. Caroline A. LitchfieldExec. VP & CFO | 2.00k | 219.73k | Derivative Exercise and Retained Stock | 110.03 | 92.30k | 2.21% |
| 2026-04-29 | Ms. Caroline A. LitchfieldExec. VP & CFO | -1.94k | 0.00 | Derivative Exercise and Sale | 110.03 | 92.30k | - |
| 2026-04-29 | Mr. Robert M. DavisChairman, President & CEO | 6.75k | 742.59k | Derivative Exercise and Retained Stock | 110.03 | 450.35k | 1.52% |
| 2026-04-29 | Mr. Robert M. DavisChairman, President & CEO | -6.55k | 0.00 | Derivative Exercise and Sale | 110.03 | 450.35k | - |
| 2026-04-29 | Mr. Johannes J. OosthuizenExec. VP and President of Oncology & MSD International | 698.00 | 76.80k | Derivative Exercise and Retained Stock | 110.03 | 21.90k | 3.29% |
| 2026-04-29 | Mr. Johannes J. OosthuizenExec. VP and President of Oncology & MSD International | -679.00 | 0.00 | Derivative Exercise and Sale | 110.03 | 21.90k | - |
| 2026-02-12 | Mr. Chirfi GuindoExec. VP of Strategic Access, Policy & Communications | -10.00k | 1.21M | 売り | 121.46 | 60.62k | -14.16% |
| 2026-02-10 | Dr. Dean Y. LiExec. VP & President of Merck Research Laboratories | -10.24k | 1.20M | 売り | 117.52 | 92.04k | -10.01% |
| 2026-02-09 | Mr. Chirfi GuindoExec. VP of Strategic Access, Policy & Communications | -10.00k | 1.18M | 売り | 118.41 | 70.62k | -12.40% |
| 2026-02-09 | Ms. Jennifer L. ZacharyExec. VP & General Counsel | -121.57k | 0.00 | Derivative Exercise and Sale | 119.15 | 68.92k | - |
| 2026-02-06 | Mr. David Michael WilliamsExec. VP and Chief Information & Digital Officer | -5.00k | 221.43k | Derivative Exercise and Sale | 77.62 - 121.91 | 30.84k | - |
| 2026-02-04 | Mr. Dalton E. SmartSenior VP of Finance, Principal Accounting Officer & Global Controller | -4.00k | 230.42k | Derivative Exercise and Sale | 62.07 - 119.68 | 8.21k | - |
| 2026-02-04 | Mr. Dalton E. SmartSenior VP of Finance, Principal Accounting Officer & Global Controller | -2.40k | 287.22k | 売り | 119.68 | 8.21k | -22.63% |
| 2026-02-06 | Mr. Johannes J. OosthuizenExec. VP and President of Oncology & MSD International | -15.00k | 1.83M | 売り | 121.87 | 21.20k | -41.44% |
| 2026-02-04 | Ms. Caroline A. LitchfieldExec. VP & CFO | -42.00k | 2.79M | Derivative Exercise and Sale | 53.06 - 119.61 | 90.19k | - |
| 2026-02-04 | Dr. Dean Y. LiExec. VP & President of Merck Research Laboratories | -15.09k | 946.35k | Derivative Exercise and Sale | 56.04 - 118.77 | 102.27k | - |
| 2026-02-05 | Mr. Chirfi GuindoExec. VP of Strategic Access, Policy & Communications | -20.00k | 2.44M | 売り | 121.88 | 80.62k | -19.88% |
| 2026-02-06 | Mr. Richard R. DeLucaExec. VP & President of Merck Animal Health | -37.69k | 4.56M | 売り | 120.92 | 160.17k | -19.05% |
| 2026-02-04 | Mr. Robert M. DavisChairman, President & CEO | -47.43k | 5.60M | 売り | 117.38 - 118.35 | 443.60k | -9.66% |
| 2025-11-10 | Ms. Cristal N. Downingインサイダー | -7.09k | 616.40k | 売り | 87.00 | 0.00 | -100.00% |
| 2025-11-03 | Mr. David Michael WilliamsExec. VP and Chief Information & Digital Officer | -8.61k | 720.04k | 売り | 83.59 | 24.58k | -25.95% |
| 2025-08-04 | Mr. David Michael WilliamsExec. VP and Chief Information & Digital Officer | 8.69k | 688.79k | Derivative Exercise and Retained Stock | 79.29 | 33.01k | 35.71% |
| 2025-08-04 | Mr. David Michael WilliamsExec. VP and Chief Information & Digital Officer | -8.43k | 0.00 | Derivative Exercise and Sale | 79.29 | 33.01k | - |
| 2025-08-04 | Mr. Chirfi GuindoExec. VP of Strategic Access, Policy & Communications | 18.73k | 1.48M | Derivative Exercise and Retained Stock | 79.29 | 89.29k | 26.54% |
| 2025-08-04 | Mr. Chirfi GuindoExec. VP of Strategic Access, Policy & Communications | -18.18k | 0.00 | Derivative Exercise and Sale | 79.29 | 89.29k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
